Ustekinumab is effective for inducing clinical, endoscopic, and radiographic response in refractory moderate-to-severe Crohn'S Disease: A multicentre cohort study
C. Ma
, R. Fedorak
, G. G. Kaplan
, L. A. Dieleman
, S. Devlin
, N. Stern
, K. I. Kroeker
, C. Seow
, Y. Leung
, K. L. Novak
, B. P. Halloran
, V. Huang
, K. Wong
, S. Ghosh
, R. Panaccione
University of Calgary
University of Alberta
University of Birmingham
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Ustekinumab is effective for inducing clinical, endoscopic, and radiographic response in refractory moderate-to-severe Crohn'S Disease: A multicentre cohort study'. Together they form a unique fingerprint.
Nursing and Health Professions
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science